Wordt geladen...
Access to new cancer medicines in Australia: dispelling the myths and informing a public debate
Despite the high level of spending on cancer medicines in Australia, consumer organisations and the pharmaceutical industry often make claims of delayed or lack of access to new cancer medicines—claims that are frequently supported by prominent coverage in the Australian media. These claims, while m...
Bewaard in:
| Gepubliceerd in: | J Pharm Policy Pract |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4823878/ https://ncbi.nlm.nih.gov/pubmed/27057313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-016-0062-x |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|